Announcements

                                                                                       

 

Telehealth Strategic Imperatives for Meeting Lifelong Consumer Trust and Care

 Tory Cenaj, Publisher

The pandemic has exponentially accelerated the adoption of virtual care and heightened consumer expectation leading health systems to reimagine their role in the sector. Adopting virtual care has empowered health systems to move beyond siloed applications to a more comprehensive, whole-person approach that consumers need across their healthcare journey. 

This opens new strategic opportunities in the virtual care market for innovators, digital health stakeholders and health systems to play an integral role in the “consumer circle of trust”. Many consumers now expect a digital option where expectations have changed forever. To build a better healthcare system, consumer expectations for healthcare must be met where quality care can be delivered virtually too!

The market will be able to accommodate better care for the consumer at a better price point ensuring a better experience with appropriate regulation. As a result, health systems can take on risk and create new value systems. Teladoc, for example, has a vision beyond large payers and employers and includes hospitals and health systems, but how does ROI factor into the equation for urgent care, chronic care, and preventive care in value-based care?  

The opportunity that virtual care presents is the future of consumerism in healthcare includes big tech companies, retailers, health plans, and NewCos disintermediating care delivery. There is tremendous opportunity for a health system to maximize the trust they have earned and established locally in the community, especially if investing in virtual care – and it pays for itself.  Many health systems start with their own employees.  ROI has been reported as high as three times the investment in the first year of launching virtual programs for chronic condition management alone.

In a fee for value world, opportunities shift to obtaining data to understand where and how to fill gaps and affect behavior change. Risk is rewarded with data insights and the ability to affect behavior change to enable healthy habits, lifestyles and enjoyment of a healthier life overall. The prototype for success is to make adjustments through predictive analytics, in real time, to meet consumers where they are.

If there are not enough primary care doctors for in-person visits and the concept of whole person care appears to resonate with many, this can be the way more virtual engagement benefits both consumer and health systems. The challenge is transitioning from fragmented products to an integrated platform where simple personalized data driven experiences are realized. Health systems are integrating whole person and virtual care with physical care across the health continuum.

Although most data should be contained in an EMR, much occurs outside the EMR. The EMR is an important foundational component, but that could limit the consumer experience. We should look beyond the EMR to capture “whole person” data.

In addition, how do we find physicians – the right physicians for the right care? Can we eliminate traditional geographic boundaries that have restricted access to a specialist into an opportunity to accelerate access to care and improve quality with newly created “Clinical Centers of Excellence” and consults on cases in rural communities?

From a technology and staff perspective, if we expect 20% of care will be conducted online hereon, what are the strategic priorities and imperatives for business?  How will value based care arrangements focus on consumerism and growth strategies? How do you expand into other markets and do so without a brick and mortar footprint? It's time to reimagine how to address those priorities including profitability at government rates. How do you deliver care and democratize access to care underserved populations? What is the purpose built platform for interoperability, scalability and clinical workflows to enable a personalized consumer experience across the entire continuum of care? Opportunities have never been greater for providers and organizations to reinvent themselves because of what's possible with virtual models of care.

To glean more and listen to the new TMT “Unscripted” Podcast Series on “The Path Forward for Whole-Person Virtual Care,” featuring Bruce Brandes, Senior Vice President of Consumer Centered Virtual Care, Teladoc Health and Dr. Lyle Berkowitz, CEO of Back9 Healthcare Consulting and Editor-in-Chief of Telehealth and Medicine Today please visit https://telehealthandmedicinetoday.com/index.php/journal

Listen to Joe DeVivo, President, Hospital and Health Systems, Teladoc Health, ConV2X 2020 Keynote address entitles “Democratizing Healthcare: Accelerating Virtual Care Adoption to Transform Care Delivery,” at https://conv2xsymposium.com

Published: 4.26.2021

 

Next Steps for Chronic Illness Care After the Taskforce on Telehealth Policy (TTP) Report

Trisha Kaundinya, BS, MD/MPH candidate;1 Rishi Agrawal, MD, MPH2      

Affiliations: 1Northwestern Feinberg School of Medicine; 2Associate Professor of Pediatrics (Hospital-based Medicine), Northwestern Feinberg School of Medicine

Telehealth experienced rapid adoption during the Covid-19 pandemic. Hence, the National Committee for Quality Assurance (NCQA), the Alliance for Connected Care, and the American Telemedicine Association (ATA) created a task force on telehealth policy (TTP) to elucidate its role post-pandemic.  TTP identified no care overutilization and fewer no-shows to appointments in analyzing preliminary pandemic data, which were primary concerns regarding telehealth. Cost-related problems also caused resistance towards a telehealth transition, but TTP identified promising cost reduction mechanisms in telehealth through more transitional care management and lowered skilled nursing transfers.1  These findings are encouraging, but to leverage them in our health system, we must address telehealth specifically in the chronic illness population.

The TTP report already addresses patients with chronic illnesses in some ways. For example, concerning data flow, TTP championed remote patient monitoring to improve patient autonomy and reduce strain on caregivers. They proposed a pilot virtual medical home and Fast Healthcare Interoperability Resource (FHIR) shared care plan, which benefits those with routine and regular follow-up requirements.

TTP also advocated to remove originating site requirements, permit audio-only telehealth when it has proven to be useful, and consider technological access as a barrier to telehealth use—challenges which are all pronounced in the chronic illness population.2

Investment in Chronic Illnesses

Many existing initiatives for telehealth administration and reimbursement support episodic care that accountable care organizations (ACOs) manage, but those with chronic illnesses are perhaps best positioned to benefit from all that a telehealth transition can offer. Currently, almost one-half of the population has at least one chronic illness, and nearly 60% of all emergency department (ED) visits are for people with at least one chronic condition.3 There is currently an apparent mismatch between the CDC’s budget for chronic illness prevention, around $4 per person per year, and our spending on those with one or more chronic illnesses, which is about $8,000 per person per year.4

This mismatch coupled with an increased incidence of chronic illnesses means more preventable deaths and increased disability-adjusted life years (DALYs). It also means high costs when care for chronic illnesses is improper: A study found that fragmented care for chronic illnesses increased average care management costs by almost $5,000 over three years.5 Racial, geographic, and socioeconomic disparities in access to care and care outcomes are also most pronounced in the chronic illness population. From all of these perspectives, telehealth has the potential to revolutionize chronic illness care.

Instead of acute episodes that mandate brief in-person evaluation, effective chronic illness management requires a longitudinally connected care team. Telehealth in the form of RPM has shown to be useful. RPM is associated with reduced hospital admissions, nursing home admissions, ED visits, and improved preventative care use.6  The epicenter of chronic illness is moving away from the clinic and into the home, so the intersection of telehealth and home health care is a keystone to successful adaptation. Home health is also associated with reduced patient mortality and hospitalizations.7 The care continuity sought after in health systems managing patients with chronic illness depends on continued prescription access and thus discussion of how this changes in a virtual setting are also warranted.8

Given the great potential of telehealth to affect chronic illness management, we have articulated some of our telehealth policy and administration recommendations that follow TTP in this patient group.

Recommendations

Remote Patient Monitoring

Remote patient monitoring (RPM) is one of the most critical telehealth modalities for patients with chronic illnesses, especially as they get older. Many prefer to maintain their independence without requiring caregivers in facilities.

Onboarding:

Earlier in the pandemic, an emergency rule expanded RPM use to new and established patients. This policy does not apply after the public health emergency ends according to the 2021 Physician Fee Schedule released by CMS. The rule needs to extend permanently post-pandemic.

Longitudinal care is one of the most significant challenges for patients with chronic illnesses, especially in rural areas with higher clinician turnover rates and lower numbers of providers. These patients would not be able to engage in telehealth and RPM in their onboarding to new providers without an in-person history and physical. The upfront convenience benefit of telehealth is lost when patients have to travel far and wait for care, and thus these patients are less likely to attend to their chronic illnesses. Patients with more complex chronic illnesses often cannot travel to establish a point of care with physicians in person and thus lose care connectivity from earlier clinicians.

Device Limitations:

The 2021 Fee Schedule mandates that in a 30-day time frame, providers can only bill once under CPT codes 99453 and 99454 for RPM independent of the number of devices patients use. Minimizing overuse of billing may be a driving incentive for this policy, but it disproportionately affects patients with multiple chronic illnesses who require many devices for their RPM. Even for patients with only one chronic illness, providers may need data from the patient’s pressure cuff, pulse oximeter, and glucose monitor, among other devices. Patients cannot be effectively managed by providers if only billed for RPM once a month. Inappropriate management of patients with multiple chronic illnesses has dire outcome and cost implications, so this requirement needs a revision that accounts for complex technology needs.9

Home Healthcare

The convenience afforded by telehealth goes hand-in-hand with the setting of home healthcare, which allows patients to sustain functionality and control over their activities of daily living. Home health has been associated with improved outcomes for patients with chronic illnesses long-term.7

CMS Reimbursement:

Throughout the Covid-19 pandemic, CMS has generated several telehealth coverage waivers for providers, but reimbursement for home health continues to trail behind. Home health aides (HHA) can legally provide telehealth services. However, these visits cannot replace in-person visits (they do not count towards the low-utilization payment adjustment (LUPA) threshold) and do not receive reimbursement as a virtual visit. HHA providers could engage in multiple mediums of telehealth to meet patient care needs, but they would still need to meet the patient in-person to bill codes covered by Medicare and meet CMS mandates. The incentive for providers to continue to provide telehealth would decrease if it is not covered. They would also be increasing Covid-19 transmission risk to an often immunocompromised population while meeting in-person expectations.

Improving coverage of telehealth for HHA has important uptake implications. One population whose engagement in telehealth long-term is limited is senior citizens, who comprise most patients for HHA. The current payment scheme disincentivizes telehealth use by HHA, when they could facilitate onboarding in a sizeable chronic illness population. Some states are relaxing rules around Medicaid coverage for HHA provision of telehealth. Thus a nationwide coverage expansion should be available for all states to opt into permanently post-pandemic.

Virtual Prescriptions

Medication adherence is a challenge for patients with chronic illnesses, especially patients with several chronic illnesses and complex care regimens. Increased adherence in this population is associated with decreased hospitalizations and ER utilization. Telehealth has a critical role in this relationship, as it can lower the additional burden of long travel and waiting times included in adherence regimens.

Opioid Use Disorders(OUD):

The 2021 Physician Fee Schedule states that through Section 3 of the SUPORT Act, effective January 1st of 2021, prescription of Schedule II-V controlled substances under Medicare Part D can be done electronically. Still, they are soliciting commentary regarding any exceptions. Recent studies have reported that Medications for Addiction Treatment (MAT) programs for those with OUD which involved telehealth had better outcomes than their in-person counterparts and that telehealth was a primary reason that patients stayed on MAT.10

When it is clear that telehealth utilization in counseling as well as the e-prescribing process improves outcomes for those with OUD, there should be permanent lifts on controlled substance prescribing restrictions. The variability in states’ decisions to modify controlled substance prescribing laws that mandate in-person office evaluation should also be mitigated by CMS to federally and permanently enable telehealth in e-prescribing MAT even after the pandemic.

The only major exception should be to physicians who work in emergent settings, which would delay or decrease the chance of the patient’s prescription filling. Emergencies for patients with OUD are often outside of typical pharmacy hours, so e-prescriptions are not successful and require the patient to return and a new prescriber would have to engage in care. The existing prescript would have to be canceled as well. Patients with opioid use disorders on MAT are at high risk of relapses when there are delays in their access to medications. In acute emergency settings, they must acquire their medication in a timely fashion and thus in-person issuing of prescriptions could be more efficient.11

Conclusion

Overall, the TTP emphasizes integration instead of devising a new telehealth infrastructure in many of their recommendations related to patient safety, quality measurement, and data flow. There is also promising preliminary telehealth data from the pandemic, but the gateway to sustainable change is effective management of the multidimensional chronic illness population in America. This population contains some of the oldest, most socioeconomically disadvantaged, least technologically involved, and most vulnerable individuals in our health system.

With the involvement of CMS, the potential benefits of a more connected healthcare system, improved patient outcomes, and lower acute episode costs can be amplified. CMS should modify RPM fee rules for patients with chronic illnesses, expand their reimbursement criteria for telehealth by home health, and enable open-ended e-prescribing requirements for MAT except for acute care settings.

References

  1. Taskforce on Telehealth Policy (TTP) Findings and Recommendations. NCQA; 2020.
  2. Nouri S, Khoong, E.C., Lyles, C.R., Karliner, L. Addressing Equity in Telemedicine for Chronic Disease Management During the Covid-19 Pandemic. New England Journal of Medicine. 2020.
  3. Kent J. Chronic Conditions Account for $8.3B in Avoidable ED Visits. Health IT Analytics 2019.
  4. Auerbach J. Prevention efforts can ward off many chronic and expensive conditions. So why aren’t we investing in them? Stat News 2017.
  5. Frandsen BR, Joynt, K.E., Rebitzer, J.B. Care Fragmentation, Quality, and Cost in Chronically Ill Patients. American Journal of managed care. 2015; 21(5).
  6. Remote Patient Management: Technology-Enabled Innovation And Evolving Business Models For Chronic Disease Care. Health Affairs. 2009;28(1):126-135.
  7. In-home care for optimizing chronic disease management in the community: an evidence-based analysis. Ont Health Technol Assess Ser. 2013;13(5):1-65.
  8. Beadles CA, Voils CI, Crowley MJ, Farley JF, Maciejewski ML. Continuity of medication management and continuity of care: Conceptual and operational considerations. SAGE Open Med. 2014;2:2050312114559261.
  9. Sambamoorthi U, Tan X, Deb A. Multiple chronic conditions and healthcare costs among adults. Expert Rev Pharmacoecon Outcomes Res. 2015;15(5):823-832.
  10. Khanna G, Chang, C. New Research Shows Promise of Telehealth in Treating Opioid Use Disorder. In. AHRQ 2020.
  11. Mehmet Sofuoglu, M.D. , Ph.D., Elise E. DeVito, Ph.D., Kathleen M. Carroll, Ph.D. Pharmacological and Behavioral Treatment of Opioid Use Disorder. Psychiatric Research and Clinical Practice. 2019;1(1):4-15.

Published 3.9.2021

 

Under Recognition of the Potential Role of Telemedicine to Speed Data Dissemination and Communication in Veterinary Medicine in the Netherlands

Jack Gommers, Dongen, The Netherlands, jcjgommers@gmail.com

Telemedicine can enhance information exchange in veterinary care. It provides triage, and, of particular importance for this post, timely follow-up regarding results of laboratory testing of livestock. Through the use of a case history, the focus here is on the author’s frustration with the current lack of remote communication and the potential role of telemedicine to speed sharing of essential information regarding risks to human and animal health.

In practice, a farmer maintains dialogue with the veterinarian who visits at least weekly. If an unknown disease strikes and analysis and diagnosis remain unclear, samples, often from dead animals, are sent to the laboratory for additional testing. In the Netherlands, this is conducted by the Animal Health Service, which sometimes forwards samples to accredited laboratories for further analysis. Based on test results, prescriptions are issued for collective treatment of the livestock or individual animals via oral or injected antibiotics.

If, as was experienced here, there is an unexpected lockdown by a governmental agency on suspicion of feed contamination, it is essential to know the diagnosis that made this action necessary. It must be remembered that family and children are at risk of unintentional contact with contamination. For rapid decision-making and to ensure public health, this is where telemedicine can be used for timely sharing of data.

In spite of the lockdown of my farm, gaining access to essential data was denied, for unclarified reasons. The Dutch government simply refused to forward laboratory results from tests carried out on my own animals. After asking the European Commission for guidance, they indicated that as a livestock farmer, I was certainly entitled to the test results of my farm. Yet, my government continued to refuse!

Despite zero tolerance required in European directives, the Dutch government tolerates finite concentrations of hormonal contaminants and pharmaceuticals in Dutch food, exported or not. According to the World Health Organization, chemical contamination might lead to acute poisoning or long-term diseases, such as cancer. Foodborne diseases might lead to long-lasting disability and even death.1

Another problem is mutation of bacterial and viral pathogens, e.g., coronaviruses.2

Coronaviruses are a large family of viruses that mutate easily. It is known for decades that they can be present in pigs, chickens, and minks in areas of intensive livestock farming. SARS-CoV-2 is the most recent virus variant of the Corona type, with dozens of mink farms infected. Millions of these animals have been killed already, to eradicate this source of infection (also in Denmark, by the way). Furthermore, SARS-CoV-2 is reported to a limited extent in pigs, chickens, dogs, and cats.

Another well-known zoonosis is the Q fever that flared in the province of North Brabant (in the south of the Netherlands) in 2007. It resulted in dozens of deaths and hundreds of people chronically ill for life. Q fever is a bacterial infectious disease that is mainly transmitted to humans by goats. Hundreds of thousands of goats were killed in the Netherlands because of this outbreak.

Officials of the European Commission pointed out to the Netherlands that all described risks to human health are unacceptable. In a parliamentary debate on this subject, with the responsible Ministers of Agriculture and Public Health, it was concluded that the Netherlands is indeed not following European guidelines 96/22 and 96/23 /EG for public health.

It is not my purpose to debate unacceptable policies at a political level here. As a farmer “in the field” my focus is on the health of my animals and the health of my family and others, by minimizing contamination risks. To this end, recognition of telemedicine is of utmost importance, as a valuable tool to facilitate the instantaneous provision of critical information and achieve the objectives advocated by the European Commission.

References

  1. Food Safety. 2020. Available at URL: https://www.who.int/news-room/fact-sheets/detail/food-safety
  2. Knobler S, Mahmoud A, Lemon S, et al., editors. Learning from SARS: Preparing for the Next Disease Outbreak: Workshop Summary. Washington (DC):National Academies Press (US); 2004. Available at URL: https://www.ncbi.nlm.nih.gov/books/NBK92442/

Published 1.29.21

TMT "Best of" Gold Open Access Articles

Now in its 3rd year of publication, join TMT’s international community of real world clinicians, consultants, researchers and innovators accelerating practical applications, services and guided solutions for patients, providers and health systems around the globe.
 
Indexed in ScienceOpen, Index Copernicus, Unpaywall, NEBIS, Google Scholar and PKP meta data harvester and member of the International Association of Scientific, Technical and Medical Publishers and DOAJTMT is read by over 88,000 viewers around the world.
 
We celebrate the “Best of” articles and invite you to become a prestigious author and member of the TMT global community of change innovators too!
 
Access articles below to inspire, educate and communicate the breakthrough research and recent pilot innovations the sector.
 
1. Role of telemedicine in healthcare during COVID-19 pandemic in developing countries
Muhammad Abdul Kadir, Department of Biomedical Physics & Technology, University of Dhaka, Dhaka Bangladesh
 
2. Telehealth Finance Variables and Successful Business Models
Bryan T. Arkwright, MHA, Director, SCP Consulting Services, Adjunct Faculty, Wake Forest University School of Law, Editorial Board, Telehealth and Medicine Today, and Co-Founder/Chief Research Officer, Cromford Health, USA
 
3. Telehealth: Legal and Ethical Considerations for Success
Claude J. Pirtle, MD, Department of Biomedical Informatics, Vanderbilt, University, Nashville, Tennessee, USA
 
4. Telehealth Governance: An Essential Tool to Empower Today’s Healthcare Leaders
Bryan Arkwright, MHA
 
5. Emergency Medical Technician-Facilitated Telehealth Visits: A New Model to Expand Home-Based Primary Care for Homebound Seniors
Karen A. Abrashkin, Northwell Health, New Hyde Park, NY, USA
 
6. Nurse Practitioners and Virtual Care: A 50-State Review of APRN Telehealth Law and Policy
Kelli M. Garber, MSN, APRN, PPCNP-BC, Lead Advanced Practice Provider and Clinical Integration Specialist, The Medical University of South Carolina Center for Telehealth, USA
 
7. Innovative Telemedicine Approaches in Different Countries: Opportunity for Adoption, Leveraging, and Scaling-Up
Amar Gupta, PhD, Massachusetts Institute of Technology, Cambridge, MA, USA
 
8. Predictive Modeling for Telemedicine Service Demand
Agni Kumar, Electrical Engineering and Computer Science Department, MIT, USA
 
9. Using the BELT Framework to Implement an mHealth Pilot Project for Preventative Screening and Monitoring of Pregnant Women in Rural Burkina Faso, Africa
Antonia Arnaert, MPH, MPA, PhD, Associate Professor, McGill University, Ingram School of Nursing, Montreal, Quebec, Canada H3A 2N7
 
Submit your manuscript here:
Questions? Reach out to info@partnersindigitalhealth.com
We look forward to your manuscript or technical brief submission.
 
TMT Team

Posted 1.20.2021

 

Transforming Health Care in the Wake of a Global Pandemic

Tory Cenaj, Publisher, Telehealth and Medicine Today

Some of the world’s top leaders and influencers in healthcare delivery transformation and health technologies, including blockchain in health tech and telehealth, converged at the 4th Annual ConVerge2Xcelerate (#CONV2X) 2020 Symposium held virtually from November 10th-12th, to exchange perspectives and solutions to shortfalls in global patient care exposed by COVID-19. The theme of this year’s symposium TMT hosted was “US-World Health Transformation.”

Impact of COVID-19 on health care

The global COVID-19 pandemic showed how vulnerable healthcare delivery is to patients around the world. Healthcare systems in every country have been challenged – not only in treating patients with coronavirus, but in trying to maintain optimal care for non-COVID patients at the same time.

As a result, new advances in digital health technologies, including telehealth, blockchain, AI and others, are transforming patient treatment models on an international scale. What this event proved is that healthcare transformation, via technology and new global models for greater access and more efficient and effective delivery of healthcare services to patients, is much closer to reality than ever before.

Many of the sessions over the two-day event focused on two main topics: healthcare interoperability, digital health, adoption, scale and equity.

Healthcare interoperability

On Day 1 of the event, this topic was highlighted by speakers from the UK, India, North America and the European Union. Interoperability is the ability of different healthcare systems and processes to communicate and share information with other healthcare systems and processes, either within or across organizational borders, in order to advance the effective delivery of healthcare. The consensus was that patients will enable interoperability through trust – a pivotal facet of adoption and scale.

Technology players will have to continue to grow in partnership with healthcare systems, which will be required for both the systems and for consumers.

Digital health

According to Keynote speaker, Dr. Tedros Adhanom Ghebreyesus, Director-General of the World Health Organization, “Digital health is a new reality that will bridge disparity and access to those with lower income and the underserved.” Other Keynotes from Teladoc Health and Mayo Clinic Digital Platform emphasized transforming health care with digital health and virtual care delivery systems, which would make care affordable and equitable, decrease disparities among income levels and geographies, and create global standards and regulations for citizens and health systems around the world.

But digital health is a broad term, one that encompasses several technologies, including telehealth, virtual care, and digital tools and services, and requiring integrations that make health care delivery broader, easier and more flexible.

A Keynote session titled, “Virtual Health: The Next Frontier for Healthcare,” with Alex Harris, Partner, McKinsey & Company and moderated by Lyle Berkowitz, MD, FACP, FHIMSS, CEO of Back9 Healthcare Consulting discussed he radical digitization of health care with supply and demand factored in. Healthcare has lagged behind other industries in terms of digitization. But on the consumer (patient) side, mindset and behavior changes have moved the needle on telemedicine visits, and it is projected that 60% of those over age 65 will avail themselves of this technology in the near future.

Physicians question the effectiveness of telehealth visits and financial compensation, and they wonder about adoption and when it will stabilize. Telehealth visits were high in April, but decreased, perhaps due to restrictions in movement as things shut down.

The challenges to adoption that still exist include funding and parity for certain services and long-term reimbursement. Fee-for-service vs. value-based is still unclear. So while providers are still wondering about financial implications, consumers are starting to feel more comfortable.

It is clear that this past year has presented both many challenges to healthcare delivery and opportunities for innovations. The manner in which health care is delivered is occurring at a time when traditional physical interaction between patient and provider has basically been a “cease and desist order” for the safety of both parties.

To learn more and get access to the agenda and program, visit https://conv2x-2020-ondemand.eventcreate.com/

For a top line introduction and select presentations visit TMT at https://telehealthandmedicinetoday.com/index.php/journal/ConV2X2020

Posted 11.20.2020

 

Building Telemedicine into the Post-COVID-19 U.S. Health Care Delivery System

Stephanie J. Zawada, M.S.

Affiliations: Mayo Clinic School of Medicine and Science, Yale University Sherwin B. Nuland Institute, American Medical Students Association

During the COVID-19 public health emergency, interest in telehealth soared to an all-time high. Specifically, telemedicine, the delivery of clinical health care services to remote patients using telecommunications tools, is seen as the most promising mode of health care delivery in the near future, with investor capital flowing into telemedicine platforms.

Regulatory waivers provided by the Centers for Medicare & Medicaid Services (CMS), executive orders issued by state governors, and mandatory social distancing measures fueled the widespread use of telemedicine during the pandemic. Healthcare stakeholders should keep the following telemedicine issues in mind as we prepare for the 2020-21 flu season:

  • Defining the services offered. The distinction between telemedicine and telehealth is critical. The Oxford dictionary defines telemedicine as “[t]he remote diagnosis and treatment of patients by means of telecommunications technology”; telehealth as “[t]he provision of healthcare remotely by means of telecommunications technology”. Telemedicine is the offering of established health care services, appropriate in scope and frequency, to remote patients - this can include remote monitoring. Telehealth describes “the wider range of ancillary health-related services and less-than-comprehensive virtual health options”.

Today, the methodological frameworks for the clinical validation of digital health technologies are still being developed. Separately defining telemedicine and telehealth services is critical to ensuring patient safety and promoting innovation. If telehealth is regulated like telemedicine, innovation will be limited. (Think about the potential of requiring artificial intelligence to pass licensure exams to deliver care.) If telemedicine is regulated like telehealth, patient safety could be compromised. (Think about online surveys where you can fill out questions to get a lifestyle drug without a doctor’s prescription. A heart attack patient in the ER who does not have this prescription in his EHR might then be prescribed drugs that lead to harmful drug interactions.)

  • Using consistent documentation. Providers should select a documentation process for telemedicine services and consistently adhere to it. One example of such an approach is in Massachusetts, where providers “include a notation in the medical record that indicates that the service was provided via telehealth [and] the technology used”. Not only will consistent documentation practices streamline the reimbursement process, but they also provide a baseline for data generated by telemedicine for research purposes.
  • Tracking drugs prescribed. The Drug Supply Chain Security Act (DSCSA) calls for an “electronic, interoperable system to identify and trace certain prescription drugs as they are distributed in the United States...to enhance FDA’s ability to help protect consumers from exposure to drugs that may be counterfeit, stolen, contaminated, or otherwise harmful”. Spurred by telehealth deregulation during the pandemic, new supply chain models for pharmaceutical compounds have emerged, such as the remote prescribing across state lines with same-day delivery. With the expansion of telemedicine, an interoperable drug tracking system, particularly for opioid prescription tracking in state prescription drug monitoring programs (PDMPs), is needed. Blockchain, a peer-to-peer (PRP) public ledger software maintained across a distributed network of computers, is one application that demonstrates potential in addressing this need.
  • Reforming policies restricting patient access. State and federal policymakers should eliminate patient location requirements, freeing patients to access telemedicine care from home. CMS’s temporary waiver allowing Medicare patients to access telemedicine care at home for the duration of the pandemic should be made permanent. In addition to removing location-based restrictions for patients seeking telemedicine care, states should follow the American Medical Association’s guideline for removing pre-existing patient-physician relationship requirements by defining the formation of said relationship when “a physician affirmatively acts in a patient’s case by examining, diagnosing, treating, or agreeing to do so”, whether in person or online.

 States should address licensure reform that allows out-of-state physicians to practice telemedicine with in-state residents. Many states temporarily implemented this approach for the duration of the pandemic. This would allow patients in rural areas with a physician shortage to access doctors in near-by states and enable patients in states without a world-renowned medical center to access telemedicine care rendered by top-ranked specialists.

  • Addressing reimbursement policies. At the start of the pandemic, many states and the federal government established temporary reimbursement parity for clinical health services delivered via telemedicine [9] [11]. Reimbursement parity for health care services levels the playing field for telemedicine as an alternative mode of health care delivery. For health care services established to be safe, appropriate in scope and frequency, and equally as effective as in-person visits, telemedicine reimbursement parity is vital to allowing physicians to offer more patient-centered care, enabling patients to choose either an in-person or telemedicine visit. Otherwise, providers will need to encourage patients to schedule in-person visits to meet revenue targets, even if a telemedicine visit would be more appropriate.

Additionally, as rural hospitals face ever-increasing financial challenges, telemedicine reimbursement parity offers them an opportunity to restructure their services. Mercy Virtual Hospital is a blueprint for adapting the delivery of health care services to meet the needs of the digital age.

  • Preparing for tax reporting. The Internal Revenue Service (IRS) has yet to update its definition of “patient”, which currently does not consider services rendered by providers at non-profit hospitals to remote patients as medical expenses. For these patients who are not admitted to the non-profit hospital, telemedicine payments may be classified as unrelated business income (UBI). When providers render telemedicine services to patients across state lines, other UBI-related rules could apply. To address these issues, the IRS definition of patient should be updated to include telemedicine-only patients and state departments of revenue should issue guidance on telemedicine-relevant UBI rules.

Business expensing for telemedicine is possible. For instance, technology investments for telemedicine practice, such as “software, hardware, or hosting fees”, may be deductible. Even 3D-printed medical devices may qualify for R&D tax credits. For telemedicine doctors using a home office, the “space and the equipment that [they] use to work from home are all part of [their] tax deduction…[as well as] part of [their] home’s utility costs, internet costs, and even mortgage” [16].

  Posted 7.31.2020

 

Telemedicine use amid COVID-19 outbreak: A global perspective

Affiliations: Md Azharuddin1, PhD, Mohammad Adil2, PhD, Prem Kapur3, MD, Pinaki Ghosh4, PhD, Manju Sharma2, PhD

1Department of Pharmaceutical Medicine, Division of Pharmacology, School of
Pharmaceutical Education and Research, Jamia Hamdard, New Delhi, India
2Department of Pharmacology, School of Pharmaceutical Education and Research, Jamia
Hamdard, New Delhi, India
3Department of Medicine, Hamdard Institute of Medical Sciences and Research, Jamia
Hamdard, New Delhi, India
4Department of Pharmacology, Poona College of Pharmacy, Bharati Vidyapeeth, Pune, India

Contact: msharma@jamiahamdard.ac.in

In December 2019, several unidentified pneumonia cases were reported in Wuhan, China, caused by β-coronavirus, a novel strain of coronavirus (2019-nCoV). On 11 February 2020, WHO officially announced “COVID-19” as the name of this new disease.1 It is steadily rising by human-to-human transmission and has confirmed 26,31839 cases worldwide, till April 24, 2020.2 The WHO declared the outbreak a global public health emergency on January 30, 2020.2 COVID-19 pandemic has put most of the countries under public health as well as economic strain.3 Several measures have taken by different countries to cope with COVID-19 outbreak. Now the global health crisis continues to escalate, telemedicine critically stepped into the spotlight in health care system to slowing the COVID-19 outbreak.

Telemedicine is the use of electronic information and telecommunications technologies including, videoconferencing, internet, store-and-forward imaging, streaming media, telephone calls and wireless communications.  It promotes and improve the vast distances patient and clinical health care by the means of interactions between patients and clinicians or between two or more consulting practitioners.4 Additionally, interactions of telemedicine have a different role in patient care. Synchronous interaction, where patients and consulting practitioners interacted in real-time. It is a two-way communication using audio-visual technology (e.g., video call). It may use to diagnose a disease, and provide treatment. Asynchronous telemedicine not providing the direct patient care, the shared information can be reviewed and answered in a delay of time between patients and consulting practitioners (e.g., e-mail).4 It may use to provide a patient care and healthcare opinion.

As the COVID-19 contributing higher fatalities among immunocompromised people like chronic diseases and comorbidities, it can be used to avoid virus exposure by the means of reducing hospital visits.5 In addition to, it can reduce the risk of COVID-19 transmission among health care professionals those working tirelessly in the frontlines by keeping all the significant infected patients out of hospital. 5 Televisiting and teleconsultation can be used to triage more patients, screen and diagnose remotely.5  

According to Infectious Diseases Society of America (IDSA), it also supports cost effective care by keeping patients to unlikely visit to emergency department and face to face consultations.6

In recent, due to wreaks havoc of COVID-19 virus, the Centers for Disease Control and Prevention (CDC) a Federal agency urging the public and healthcare professional to use telehealth programs for communication in an effort to reduce the burden of unnecessary emergency rooms and clinics visits.

The World Health Organization (WHO), CDC, as well as several state public health agencies have suggested that telemedicine service must considered as an essential part of healthcare provider in “strengthening the Health Systems Response to COVID-19” policy. In addition, according to a new WHO policy, within the adequate service delivery action, it should be considered as one of the alternative models for clinical services and clinical decision support.

A survey carried out among U.S. patients have shown that 84% are more likely to choose those providers who offers telemedicine. In Israel, a TytoCare’s telehealth solution has launched a TytoHomeTM kit to examine COVID-19 patients in quarantine wards, as well as to monitor patients in isolation stays and home quarantine.5

TytoCare’s partners is all set to emerged the solution and expanded their use in the US and Europe.  In recent March 25, 2020, the American Medical Association (AMA) launches telemedicine during COVID-19 outbreak, where physicians and experts can discuss the several issues and share the experiences over the ongoing pandemics. Also, the Government agencies are associated with industry leaders in virtual care. Ro is a patient-driven virtual telehealth company launched a digital health clinic, now it became a part of the White House’s Tech Task Force for coronavirus, aims to be the patient's first call for all of their healthcare needs.7

On March 25, 2020, the Indian Ministry of Health and Family Welfare (MoHFW) with NITI Aayog and Board of Governors (BoG) Medical Council of India (MCI) launched the official guidelines for telemedicine practices to prevent transmission of virus.8 Advised all the registered medical practitioners and doctors to provide and support healthcare services remotely via phone or online communication consultation where citizen go on nationwide lockdown for 21 days. Under this consideration, doctors can write prescriptions based on receiving telephonic, textual or video conversations-chat, images, messaging, emails, fax and others.8

This is a crucial step for digital health, and the decision has been lauded by current digital healthcare solutions, who believed that this is the need of the hour especially when the world is facing unprecedented challenges with the coronavirus pandemic.

Furthermore, there are several online health services such as Practo, 1mg, Medlife, mFine, significantly stepped in online    consultations during the COVID-19 pandemics, where 1mg claimed a 300% rise in e-consultations for flu and fever-related illnesses since the beginning of March 2020. The telecommunication received from across the country, nearly 600 cities and towns. In addition, Practo, an online doctor-consultation service reported that, it sharply increases in telemedicine calls after a week since the first confirmed case of COVID-19 in India.9 Additionally, the USA, Israel, UK, Nordics and France are amongst the leading countries with established telehealth providers, and their cumulative experience is helping to respond to the current situation.10

This study briefly addressed the global perspectives towards use of telemedicine, in order to deliver and ensure the patient health and safety of health care professionals. Therefore, all countries are suggested to use telemedicine during this pandemic and set up an infrastructure for the next inevitable, infectious disease, if emerge.

Acknowledgement

Sun Pharmaceuticals, India, for providing assistantship for this project under the joint collaboration for the Ph.D. programme with Jamia Hamdard, New Delhi, India.

References:

  1. World Health Organization website. Novel Coronavirus (2019-nCoV) Situation Report-1 https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200121-sitrep-1-2019-ncov.pdf. Accessed April 12, 2020.
  2. World Health Organization website. Coronavirus disease (COVID-19) Pandemic. https://www.who.int/emergencies/diseases/novel-coronavirus-2019. Accessed April 25, 2020
  3. McKibbin WJ, Fernando R. The global macroeconomic impacts of COVID-19: Seven scenarios. SSRN Elec J. 2020.
  4. American Telemedicine Association. Telemedicine glossary. Available at: https://thesource.americantelemed.org/resources/telemedicine-glossary. Accessed April 12, 2020.
  5. Telemedicine during COVID-19: Benefits, limitations, burdens, adaptation. HealthcareITNews. Bill Siwicki. March 19, 2020. https://www.healthcareitnews.com/news/telemedicine-during-covid-19-benefits-limitations-burdens-adaptation. Accessed April 12, 2020.
  6. Young JD, Abdel-Massih R, Herchline T, McCurdy L, Moyer KJ, Scott JD, Wood BR, Siddiqui J. Infectious Diseases Society of America position statement on telehealth and telemedicine as applied to the practice of infectious diseases. Clinical Infectious Diseases. 2019 Apr 24;68(9):1437-43.
  7. Apple releases COVID-19 screening tool, resource guide. Mobihealthnews. Laura Lovett. March 27, 2020. https://www.mobihealthnews.com/news/apple-releases-covid-19-screening-tool-resource-guide. Accessed April 12, 2020.
  8. Telemedicine Practice Guidelines. Board of Governors in supersession of the Medical Council of India. https://www.mohfw.gov.in/pdf/Telemedicine.pdf. Accessed April 12, 2020.
  9. Telemedicine takes spotlight in season of flu. The Economic Times; Healthcare. Alnoor Peermohamed. Mar 16, 2020. https://economictimes.indiatimes.com/industry/healthcare/biotech/healthcare/telemedicine-takes-spotlight-in-season-of-flu/articleshow/74642448.cms?from=mdr. Accessed April 12, 2020.
  10. Telehealth in the time of COVID-19. Mobihealthnews. Marianna Imenokhoeva. March 31, 2020. https://www.mobihealthnews.com/news/europe/telehealth-time-covid-19. Accessed April 12, 2020.

 Posted 5.19.2020

 

Why Veterinary TeleHealth is Critical to Keeping Our Pets (And Ourselves) Healthy During - And After - the COVID-19 Crisis

Hannah Cheng Lau, DVM 

I have been very lucky to work almost exclusively in the field of veterinary telemedicine for over a year. I see patients over video and phone consults for a myriad of issues that can be managed at home. Planning, implementing, and troubleshooting a well-rounded telemedicine program in our large 30-veterinarian hospital has been exciting, new, and intimidating for everyone involved. A year ago we had no idea how extensively the program would be put to the test with the public health crisis that is COVID-19. Telehealth has a whole new purpose in this new reality. We have realized that while trying to ride the wave of current events, many of our colleagues are just dusting off their surfboards - or even more concerning, are still sitting on the beach.

I believe strongly that telehealth is an essential organ in the veterinary beast - and it has been for years. Telehealth has always been a part of any veterinary business, and it happens every day in every practice around the world. Like any untrained muscle, it can be challenging and uncomfortable to intentionally strengthen it - but it ​has ​ always been there. When I speak to my colleagues about telehealth, the first thing I remind them of is that they are already doing it. Granted, a big portion of this is done by paraprofessional staff: mainly client service representatives, veterinary nurses, and assistants. Teletriage and teleadvice is being regularly performed over the phone, either when the client first contacts the clinic, or as veterinary nurse consults. Continuing care is also done daily on the phone, through email, or with voicemail tag. All of these communications, when done well, take hours of employee time and require years of professional and on-the-job training. Although the medium of multiple phone calls and voicemails feels familiar and therefore comforting, they are inefficient to document, confusing for a third party to interpret, and difficult to monetize.

With the continuing effects of COVID-19 stretching out with unknown horizons into the future, likely resulting in a society that is forever changed, it is naive and perhaps negligent to assume life will return to “normal” and telemedicine will become a dying fad. COVID-19 has underlined the importance of telemedicine to the general populace by helping clients and providers socially distance and reduce unnecessary travel. However, this has always been and will continue to be a concern for many of our clients even without a worldwide health crisis. COVID-19 has opened all of our eyes to the dangers and anxieties of navigating the world as someone who is immunocompromised. However, those concerns will continue to exist for our community members who are battling illness, differently abled, do not have access to transportation, or are away from home. Human medicine has trailblazed this space already, and offering virtual doctor’s visits has become more and more accepted with readily observed advantages in convenience and patient access. Deeming telemedicine as unnecessary or too risky for practitioners is the coward’s way out of developing better care for the marginalized.

In addition to providing better care for clients, I have seen patients benefit greatly from well-utilized telemedicine. I am the first to agree that the physical exam is the cornerstone of good veterinary medicine, and telehealth must be used shrewdly and with careful judgement (just like every other tool in the veterinary arsenal). However, there are many common consults that fit beautifully into the virtual space. Very anxious pets can experience stress-free vet consults in their comfort zone, with no danger of canine scuffles in the lobby or losing an escape artist cat in the parking lot. Exposure to infectious illness in the hospital can be reduced. Without the adrenaline of the hospital and white coat syndrome, I can often get a more accurate picture of what the client is seeing at home. Behavioral issues, good husbandry techniques, new puppy education, mild/moderate skin issues, acute lameness, diarrhea, and many other common issues can be discussed at length and often successfully treated. To be abundantly clear - telemedicine is not the space for the lethargic or very painful pet, the intractably vomiting pet, or the nonambulatory pet, just as these cases are not to be handled solely over the phone. There are still issues that must be seen in the hospital. There is no escaping using good judgement, and there is never a one size fits all for every situation. Luckily, this is nothing new to the experienced veterinary practitioner.

I too am clinging to the hope that soon things will be “back to normal.” However, COVID-19 has opened our collective eyes to the many advantages of conducting telemedicine in a purposeful and intentional way - in which an effective medium is used, efficient and thorough documentation is maintained, and the client is charged at a fair rate for a practitioner’s undivided time and attention. Clients will expect us to continue to provide this service even when social distancing becomes less critical for the average community member. Many veterinary practices have realized that a well-established telehealth program increases efficiency, revenue, and client satisfaction. Necessity being the mother of invention, this era of unprecedented challenges is also the birthplace of triumphant problem-solving. A sure way to add to this pandemic’s staggering losses to humanity would be to emerge on the other side refusing to embrace new technologies and ideas in order to grow, both as a profession and as a community. That said, this is neither the first nor the last challenge we will face together as a field, and small-minded fear is not a new enemy. I have abundant faith that we will not allow it to guide us going forward, and instead choose to explore exciting new ways to relieve animal suffering and protect global health.

Posted 5.15.2020

 

Telemedicine: From Green Eggs and Ham to Bread and Butter 

Richard B. Sanders

Affiliations: American College of Healthcare Executives, Society of Hospital Medicine – (Former Section Leader for the Rural Hospitalist Section), American Telemedicine Association

As the COVID-19 pandemic presses upon the world, it has acutely changed our concept of social engagement, as well as the practice of medicine. The pillars of policy and regulation that have previously restricted the otherwise bright future of telemedicine and virtual health are cracking.

Penned by a self-proclaimed early adopter and advocate for telemedicine, this opinion piece offers four (4) considerations for turning telemedicine from “Green Eggs and Ham” into “bread and butter” in post-COVID-19 responses.

In “Green Eggs and Ham,” the popular children’s book by Dr. Seuss, a persistent yet unpersuasive Sam attempts to convince the reluctant Guy to try his favorite delicacy. But no matter whether on a boat or a train, in a house, or even in the company of his favorite animal, Guy is uninterested in sampling such a visibly unappealing meal. Yet Sam’s persistence pays off when Guy, in an attempt to get Sam to leave him alone, finally agrees to try the green eggs and ham. At that point, Guy realizes what he had been missing all along!

As an early evangelizer of telemedicine, I felt much like Seuss’ character, Sam. I started to point my healthcare career toward telemedicine and virtual health in 2007 when a visionary CEO looked to create new value for patients and caregivers. I immediately bought into his mission of technologically enabling the hospitalist workforce. This work propelled me into the world of innovation and advanced educational pursuits where I spoke to national and international audiences, obtained a doctoral degree, and published articles in the journal of Telemedicine and e-Health.

Over the years and after many odd hours and late nights of pioneering new territory in the heavily entrenched healthcare industry, I got the impression that those who had yet to see the efficacy of telemedicine viewed my physician friends, administrative colleagues, and me as dreamers. Like Sam, I persistently recommended solutions that if the hospital or physician would just simply try, they would find appealing and perhaps even transformational. I know others’ collective experience in being early adopters of telemedicine have been the same. Although initial resistance was the norm, once a telemedicine solution was deployed the organization was never the same.

As the COVID-19 pandemic presses upon the world, it